Policy & Advocacy News

Archives

C3 Submits Comments to the FDA’s Oncology Drug Advisory Committee

The Food and Drug Administration’s (FDA) Oncology Drug Advisory Committee (ODAC) is meeting today to discuss whether the labels for Erbitux (cetuximab) and Vectibix (panitumumab) should include a mention of KRAS testing. The discussion at the meeting will have implications for future development of companion diagnostics. C3 President Carlea Bauman will be testifying during the public comment section: Continue reading…

Posted by Joe Arite on December 16th, 2008
Posted in: C3 News, Policy & Advocacy News, Research & Treatment News | 1 Comment »
Tags: Erbitux, FDA, KRAS, ODAC, Vectibix

Daschle Named Secretary of HHS

Former Senator Tom Daschle (D-SD)

Former Senator Tom Daschle (D-SD)

President Elect Barack Obama formally announced former Senator Tom Daschle as his pick for Secretary of Health and Human Services (HHS) on Thursday. Daschle is also expected to serve as the Director of the White House Office of Health Reform. Continue reading…

Posted by Joe Arite on December 11th, 2008
Posted in: Policy & Advocacy News | No Comments »
Tags: Daschle, Obama, President of the United States

Kennedy to Step Down from Judiciary Committee

Senator Ted Kennedy (D-MA)

Senator Ted Kennedy (D-MA) announced he will be stepping down from the Senate Judiciary Committee in the 111th Congress to focus on health care reform. As chairman of the Senate Health, Education, Labor and Pensions Committee, I expect to lead a very full agenda in the next Congress, including working with [President-elect] Obama to guarantee affordable health care, at long last, for every American,Kennedy said. Continue reading…

Posted by Joe Arite on December 9th, 2008
Posted in: Policy & Advocacy News | No Comments »
Tags: Baucus, Healthcare Reform, Obama, Senate, Senator Kennedy

It’s Time to Move Forward

President Elect Obama has plenty of challenges ahead of him. Issues ranging from the economy, energy, the environment, and of course healthcare will be at the top of his policy agenda. He has also pledged to reinvigorate the war against cancer. To accomplish this he has promised to double federal funding for cancer research and ensure all Americans have access to preventative healthcare screenings; including those that will detect, and possibly prevent, colorectal cancer.

Take this opportunity to email him directly and hold him to his word. President Elect Obama, make colorectal cancer screening and treatment a national priority! Click here to Take Action

Posted by Joe Arite on December 4th, 2008
Posted in: Policy & Advocacy News | No Comments »
Tags: colorectal cancer prevention, Obama, President of the United States

NIH Funding Included in Possible Senate Recovery Package

Senate Majority Leader Harry Reid (Nevada) and Senate Appropriations Committee Chairman Robert C. Byrd (West Virginia) unveiled a $100.3 billion economic recovery package. Continue reading…

Posted by Joe Arite on November 18th, 2008
Posted in: Policy & Advocacy News | 1 Comment »
Tags: Congress, Senate

Search C3

New to C3?

Get monthly updates on colorectal cancer treatment options, research news and advocacy opportunities. We promise to not bombard you with email - just enough to keep you informed on how to fight colorectal cancer.

First Name

Last Name

Email

Sign Our Petition

Guarantee access to colorectal cancer screening for all Americans who need it.

Get Involved

Call-on Congress 2009

Registration now open!

March 22-25, 2009
Washington, DC

more information

Donate

Support C3 and the Lisa Fund for Research

Donate to C3

Donate to The Lisa Fund

Learn more about the Lisa Fund

Awareness Gear

Order pins, bracelets and other materials

Order Now

Shop for the Cause

Buy a camera and help fight colorectal cancer.

Shop Now

Get Momentum

Winter 2009 issue available now.

Download Now

Subscribe to the C3 website

Get C3 news & updates

Get the latest articles in your email inbox or news reader as soon as they are published.

Subscribe

Is Your Butt Covered?

Accreditation

We comply with the HONcode standard for trustworthy health information:
verify here.